Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Editor's Pick

Incorporating Patient-Reported Outcomes into the Clinic

Katie Robinson  |  May 5, 2025

‘Measuring patient-reported outcomes (PROs) is an important component of high-quality, patient-centered care, but integration of PROs into clinic can be challenging,’ says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘Luckily, tools exist to help us realize this vital aspect of patient care.’ The ACR’s quality measures for care include gauging disease activity and…

Filed under:EMRsPatient PerspectivePractice Support Tagged with:patient reported outcomes

FDA Approves Suzetrigine (VX-548), a Non-Opioid Analgesic

Michele B. Kaufman, PharmD, BCGP  |  April 29, 2025

Based on research in post-surgery patients, the FDA approved suzetrigine, a non-opioid analgesic, for the treatment moderate to severe, acute pain in adults.

Filed under:AnalgesicsDrug Updates Tagged with:acute painFDAFDA approvalsuzetrigineU.S. Food and Drug Administration (FDA)VX-548

Colin Edgerton, MD, Testifies in Congressional Hearing on Biosimilars

Vanessa Caceres  |  April 21, 2025

In front of the U.S. House Ways and Means Subcommittee, Dr. Edgerton described how challenges of biosimilar costs threaten patient care and outlined several potential legislative solutions.

Filed under:InsuranceLegislation & Advocacy Tagged with:BiosimilarsWays and Means Committee

FDA Approves Oral Solution of Colchicine to Prevent Gout Flare

Michele B. Kaufman, PharmD, BCGP  |  April 9, 2025

The FDA approved an oral solution of colchicine for the prevention of gout flare in adults. Its dosage can be easily adjusted on the basis of patient needs.

Filed under:AnalgesicsConditionsDrug UpdatesGout and Crystalline Arthritis

Doctor is using the tablet to send the data to the virtual reality glasses showing the health diagnosis as the patient is wearing and analyzing together at home.

Virtual Reality: An Immersive Educational Experience

Jason Liebowitz, MD, FACR  |  April 8, 2025

Virtual reality technology may be a unique and immersive avenue for educating patients on rheumatic conditions and their treatments, with the potential to enable more informed decision making and improve care.

Filed under:AppsEducation & TrainingTechnology Tagged with:appsEducationpatient educationTechnologyvirtual reality

Semaglutatide for Patients with Knee Osteoarthritis?

Bryn Nelson, PhD  |  April 8, 2025

Based on decades of data from dietary and other lifestyle interventions, doctors have long known that significant weight loss can be an effective treatment for people who are overweight and have knee osteoarthritis (OA). One meta-analysis showed that OA pain, function and stiffness scores improved by 2% for every 1% in lost weight.1 But the…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:knee osteoarthritisResearch Reviewresearch reviewssemaglutideweight loss

Rheumatology Influencers: Dr. Huffstutter Leads with Purpose

Linda Childers  |  April 8, 2025

As president elect of the Tennessee Medical Association (TMA), J. Eugene Huffstutter, MD, FACP, FACR, MACR, a rheumatologist with Arthritis Associates in Hixson, Tenn., says one of his priorities as the new president of the Tennessee Medical Association (TMA) is ensuring physicians can focus on practicing medicine without unnecessary obstacles. Dr. Huffstutter expresses concern about…

Filed under:Profiles Tagged with:Access to careDr. Eugene Huffstutterprior authorizationRheumatology Influencers

New Study Probes Risks Related to Acetaminophen Use

Vanessa Caceres  |  April 7, 2025

A new study questions whether acetaminophen is a risk-free pain reliever for patients aged 65 and older, including those with osteoarthritis (OA). Although acetaminophen is often touted as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, a population-based cohort study found it carried an increased risk of peptic ulcers, bleeding and other side…

Filed under:AnalgesicsDrug UpdatesOsteoarthritis and Bone DisordersResearch Rheum Tagged with:acetaminophenResearch Reviewresearch reviewsTylenol

State Legislative Update, Spring 2025

Joseph Cantrell, JD  |  March 24, 2025

With the state legislative session in full swing, the ACR is currently tracking 114 pieces of state legislation across many issue areas, including utilization management, prescription drug review boards and vaccines.

Filed under:Legislation & AdvocacyPractice Support Tagged with:ACR advocacyloan forgivenessPDABstate legislationvaccinationvaccines

CMS Nominee Mehmet Oz’s Stated Policy Priorities & Rheumatology

Colby Tiner, MA  |  March 23, 2025

With Mehmet Oz, MD, expected to be confirmed as administrator of the Centers for Medicare & Medicaid Services, the ACR considers how his stated priorities may affect rheumatology.

Filed under:Legislation & Advocacy Tagged with:ACR advocacyCenters for Medicare & Medicaid Services (CMS)federal administration

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences